The campaign for the U.S. Senate in Connecticut, where I live, has produced commercials that are so nasty (and insulting to the intelligence) that I often catch myself wishing that somehow both candidates might lose.
GlaxoSmithKline Plc’s Avandia was linked to heart attacks and other cardiovascular complications in two new studies that the authors say should prompt U.S. regulators to pull the diabetes drug from the market.
Hong Kong Exchanges and Clearing Ltd., the world’s biggest bourse operator by market value, named Romnesh Lamba and Martin Abbott co-heads of global markets as it completes its takeover of the London Metal Exchange.
Galleon Group LLC founder Raj Rajaratnam will get a court hearing on his claim that the government filed a misleading application to wiretap him and that the evidence produced by the taps should be excluded.
A U.S. advisory panel’s call for stronger warnings about heart risks tied to GlaxoSmithKline Plc ’s diabetes drug Avandia may further erode sales that had already been dropping over the last two years.
UBS AG hired Chul Chung from Goldman Sachs Group Inc. to be co-general counsel for its investment bank as Switzerland’s largest bank navigates the biggest overhaul of U.S. financial regulation since the Great Depression.
Half of the 21 drugs pulled from the market in the U.S. for safety reasons since 1995 involved heart complications, a finding that is spurring Congress and doctors to call for closer government review of side effects.